Identification of candidate methylation-responsive genes in ovarian cancer

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Menendez, Laura ^a   Walker, De Ette ^b,c   Matyunina, Lilya V ^b,c   Dickerson, Erin B ^b,c   Bowen, Nathan J ^b,c   Polavarapu, Nalini ^b,c   Benigno, Benedict B ^c   McDonald, John F ^b,c  

^a University of Georgia ^*  (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c Ovarian Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ARTICLE; CANCER CELL; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC EPIGENESIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CARCINOMA; OVARY CELL; PREDICTION; PROMOTER REGION; PROTEIN METHYLATION; UNINDEXED SEQUENCE; UPREGULATION; VALIDATION STUDY;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; OVARIAN NEOPLASMS;

EID: 33847609658     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-10     Document Type: Article

References (30)

1. Crijns AP Duiker EW de Jong S Willemse PH van der Zee AG de Vries EG Molecular prognostic markers in ovarian cancer: Toward patient-tailored therapy Int J Gynecol Cancer 2006 16 Suppl 1 152-165 10.1111/ j.1525-1438.2006.00503.x 16515584
2. Esteller M Epigenetics provides a new generation of oncogenes and tumour-suppressor genes Br J Cancer 2006 94 179-183 10.1038/ sj.bjc.6602918 16404435
3. Herman JG Baylin SB Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 2003 349 2042-2054 10.1056/ NEJMra023075 14627790
4. Gardiner-Garden M Frommer M CpG islands in vertebrate genomes J Mol Biol 1987 196 261-282 10.1016/0022-2836(87)90689-9 3656447
5. Ibanez de Caceres I Battagli C Esteller M Herman JG Dulaimi E Edelson MI Bergman C Ehya H Eisenberg BL Cairns P Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients Cancer Res 2004 64 6476-6481 10.1158/ 0008-5472.CAN-04-1529 15374957
6. Makarla PB Saboorian MH Ashfaq R Toyooka KO Toyooka S Minna JD Gazdar AF Schorge JO Promoter hypermethylation profile of ovarian epithelial neoplasms Clin Cancer Res 2005 11 5365-5369 10.1158/ 1078-0432.CCR-04-2455 16061849
7. Teodoridis JM Hall J Marsh S Kannall HD Smyth C Curto J Siddiqui N Gabra H McLeod HL Strathdee G Brown R CpG island methylation of DNA damage response genes in advanced ovarian cancer Cancer Res 2005 65 8961-8967 10.1158/0008-5472.CAN-05-1187 16204069
8. Lodygin D Epanchintsev A Menssen A Diebold J Hermeking H Functional epigenomics identifies genes frequently silenced in prostate cancer Cancer Res 2005 65 4218-4227 10.1158/0008-5472.CAN-04-4407 15899813
9. Mund C Hackanson B Stresemann C Lubbert M Lyko F Characterization of DNA demethylation effects induced by 5-Aza-2′-deoxycytidine in patients with myelodysplastic syndrome Cancer Res 2005 65 7086-7090 10.1158/0008-5472.CAN-05-0695 16103056
10. Suzuki H Gabrielson E Chen W Anbazhagan R van Engeland M Weijenberg MP Herman JG Baylin SB A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer Nat Genet 2002 31 141-149 10.1038/ng892 11992124
11. Takai N Kawamata N Walsh CS Gery S Desmond JC Whittaker S Said JW Popoviciu LM Jones PA Miyakawa I Koeffler HP Discovery of epigenetically masked tumor suppressor genes in endometrial cancer Mol Cancer Res 2005 3 261-269 10.1158/1541-7786.MCR-04-0110 15886297
12. Rivenbark AG Jones WB Risher JD Coleman WB DNA Methylation-Dependent Epigenetic Regulation of Gene Expression in MCF-7 Breast Cancer Cells Epigenetics 2006 1 e1-12
13. Wang Z Zhang J Zhang Y Lim SH SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically Int J Cancer 2006 118 1436-1444 10.1002/ijc.21499 16187275
14. De Smet C Lurquin C Lethe B Martelange V Boon T DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter Mol Cell Biol 1999 19 7327-7335 84726 10523621
15. Sunaga N Miyajima K Suzuki M Sato M White MA Ramirez RD Shay JW Gazdar AF Minna JD Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer Cancer Res 2004 64 4277-4285 10.1158/0008-5472.CAN-03-3941 15205342
16. Sigalotti L Coral S Nardi G Spessotto A Cortini E Cattarossi I Colizzi F Altomonte M Maio M Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma J Immunother 2002 25 16-26 10.1097/00002371-200201000-00002 11924907
17. Alaminos M Davalos V Ropero S Setien F Paz MF Herranz M Fraga MF Mora J Cheung NK Gerald WL Esteller M EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma Cancer Res 2005 65 2565-2571 10.1158/0008-5472.CAN-04-4283 15805250
18. Cameron EE Bachman KE Myohanen S Herman JG Baylin SB Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 1999 21 103-107 10.1038/5047 9916800
19. Vanaja DK Cheville JC Iturria SJ Young CY Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression Cancer Res 2003 63 3877-3882 12873976
20. Chen ST Lin SY Yeh KT Kuo SJ Chan WL Chu YP Chang JG Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers Int J Mol Med 2004 14 577-582 15375584
21. Yu Y Xu F Peng H Fang X Zhao S Li Y Cuevas B Kuo WL Gray JW Siciliano M NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas Proc Natl Acad Sci USA 1999 96 214-219 15119 9874798 10.1073/pnas.96.1.214
22. Venter JC Adams MD Myers EW Li PW Mural RJ Sutton GG Smith HO Yandell M Evans CA Holt RA The sequence of the human genome Science 2001 291 1304-1351 10.1126/science.1058040 11181995
23. Jones PA Laird PW Cancer epigenetics comes of age Nat Genet 1999 21 163-167 10.1038/5947 9988266
24. Ducasse M Brown MA Epigenetic aberrations and cancer Mol Cancer 2006 8 5 60 10.1186/1476-4598-5-60
25. Plass C Smiraqlia DJ Genome-wide analysis of DNA methylation changes in human malignancies Curr Top Microbiol Immunol 2006 310 179-198 16909911
26. Dannenberg LO Edenberg HJ Epigenetics of gene expression in human hepatoma cells: And histone deacetylation BMC Genomics 2006 7 181 1574318 16854234 10.1186/1471-2164-7-181
27. Yuan BZ Jefferson AM Popescu NC Reynolds SH Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2′-deoxycytidine Neoplasia 2004 6 412-419 1502114 15256063 10.1593/neo.03490
28. Yamashita S Tsujino Y Moriquchi K Tatematsu M Ushijima T Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray Cancer Sci 2006 97 64-71 10.1111/j.1349-7006.2006.00136.x 16367923
29. Tusher VG Tibshirani R Chu G Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 2001 98 5116-5121 33173 11309499 10.1073/pnas.091062498
30. http://www.affymetrix.com/analysis/index.affx